These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38677063)

  • 1. Tiered Pricing and Alternative Mechanisms for Equitative Access to Vaccines in Latin America: A Narrative Review of the Literature.
    Arango-Luque A; Yucumá D; Castañeda CE; Espin J; Becerra-Posada F
    Value Health Reg Issues; 2024 Jul; 42():100981. PubMed ID: 38677063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to medicines and hepatitis C in Africa: can tiered pricing and voluntary licencing assure universal access, health equity and fairness?
    Assefa Y; Hill PS; Ulikpan A; Williams OD
    Global Health; 2017 Sep; 13(1):73. PubMed ID: 28903757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving access to vaccines through tiered pricing.
    Berkley S
    Lancet; 2014 Jun; 383(9936):2265-7. PubMed ID: 24636625
    [No Abstract]   [Full Text] [Related]  

  • 4. Lessons learned in shaping vaccine markets in low-income countries: a review of the vaccine market segment supported by the GAVI Alliance.
    Gilchrist SA; Nanni A
    Health Policy Plan; 2013 Dec; 28(8):838-46. PubMed ID: 23174880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature.
    Ocran Mattila P; Ahmad R; Hasan SS; Babar ZU
    Front Public Health; 2021; 9():628744. PubMed ID: 33996712
    [No Abstract]   [Full Text] [Related]  

  • 6. Tiered pricing of vaccines: a win-win-win situation, not a subsidy.
    Plahte J
    Lancet Infect Dis; 2005 Jan; 5(1):58-63. PubMed ID: 15620562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public support in the United States for global equity in vaccine pricing.
    Chan Y; Datt G; Islam A; Rai B; Wang LC
    Sci Rep; 2022 May; 12(1):8960. PubMed ID: 35624169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines as a global imperative--a business perspective.
    Stéphenne J
    Health Aff (Millwood); 2011 Jun; 30(6):1042-8. PubMed ID: 21653955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine Prices: A Systematic Review of Literature.
    Hussain R; Bukhari NI; Ur Rehman A; Hassali MA; Babar ZU
    Vaccines (Basel); 2020 Oct; 8(4):. PubMed ID: 33137948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mixed integer programming model for vaccine pricing within a group purchasing organization.
    Yu Z; Keskinocak P; Orenstein WA; Toktay LB
    Vaccine; 2024 Mar; 42(8):1892-1898. PubMed ID: 37977944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Prices and Affordability of Cancer Medicines in 16 Countries in Europe and Latin America.
    Moye-Holz D; Vogler S
    Appl Health Econ Health Policy; 2022 Jan; 20(1):67-77. PubMed ID: 34228312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing affordability and profit in a non-cooperative, coordinated, hypothetical pediatric vaccine market via sequential optimization.
    Alves-Maciel B; Proano RA
    Health Care Manag Sci; 2024 Jun; ():. PubMed ID: 38951318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries.
    Moon S; Jambert E; Childs M; von Schoen-Angerer T
    Global Health; 2011 Oct; 7():39. PubMed ID: 21992405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IMPLICATIONS OF GLOBAL PRICING POLICIES ON ACCESS TO INNOVATIVE DRUGS: THE CASE OF TRASTUZUMAB IN SEVEN LATIN AMERICAN COUNTRIES.
    Pichon-Riviere A; Garay OU; Augustovski F; Vallejos C; Huayanay L; Bueno Mdel P; Rodriguez A; de Andrade CJ; Buendía JA; Drummond M
    Int J Technol Assess Health Care; 2015 Jan; 31(1-2):2-11. PubMed ID: 25989703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addressing supply side barriers to introduction of new vaccines to the developing world.
    McElligott S
    Am J Law Med; 2009; 35(2-3):415-41. PubMed ID: 19697757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential pricing for pharmaceuticals: reconciling access, R&D and patents.
    Danzon PM; Towse A
    Int J Health Care Finance Econ; 2003 Sep; 3(3):183-205. PubMed ID: 14625999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Improving global access to new vaccines: intellectual property, technology transfer, and regulatory pathways].
    Crager SE
    Rev Panam Salud Publica; 2015 Jan; 37(1):59-68. PubMed ID: 25791189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 2023 Latin America report of the
    Hartinger SM; Palmeiro-Silva YK; Llerena-Cayo C; Blanco-Villafuerte L; Escobar LE; Diaz A; Sarmiento JH; Lescano AG; Melo O; Rojas-Rueda D; Takahashi B; Callaghan M; Chesini F; Dasgupta S; Posse CG; Gouveia N; Martins de Carvalho A; Miranda-Chacón Z; Mohajeri N; Pantoja C; Robinson EJZ; Salas MF; Santiago R; Sauma E; Santos-Vega M; Scamman D; Sergeeva M; Souza de Camargo T; Sorensen C; Umaña JD; Yglesias-González M; Walawender M; Buss D; Romanello M
    Lancet Reg Health Am; 2024 May; 33():100746. PubMed ID: 38800647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could international compulsory licensing reconcile tiered pricing of pharmaceuticals with the right to health?
    Ooms G; Forman L; Williams OD; Hill PS
    BMC Int Health Hum Rights; 2014 Dec; 14():37. PubMed ID: 25518744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.